trial · primary record
Erdafitinib Intravesical Delivery System
Urinary Bladder Neoplasms
| Phase | Phase 1 |
|---|---|
| Status | COMPLETED |
| Sponsor | Unknown |
| Enrolment | 5 |
| Primary completion | 2025-10-31 |
| Primary endpoint | Number of Participants with Dose-limiting Toxicity (DLT) |
| Registry ID | NCT05567185 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-04T03:54:50.425Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT05567185
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.
Same entity, elsewhere in the suite
- Erdafitinib Intravesical Delivery System · compound